Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response

ANTONIO MANUEL AGRAZ DOBLASVÍCTOR GARCÍA VIOQUERAUL MIGUEL LUQUE HUERTASEMILIA Mª ALORS PÉREZJUSTO PASTOR CASTAÑO FUENTESALEJANDRO IBÁÑEZ COSTAMANUEL DAVID GAHETE ORTIZFRANCISCO GRACIA NAVARRO2026-01-292026-01-29202410.1016/j.omtn.2023.1020902-s2.0-85180331994https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37255Drug DiscoveryMolecular MedicineAltered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus responseresearch article